Novartis Investigative Site

Beltsville, Maryland 20705

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction, Obesity, Overweight

Studies at this site

• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early